![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GLAXOSMITHKLINE TO SET UP EUR 100 M VACCINE PLANT IN HUNGARY
GLAXOSMITHKLINE TO SET UP EUR 100 M VACCINE PLANT IN HUNGARY
September 6, 2006
GlaxoSmithKline (GSK), one of Hungary's largest investors in the drugs industry, is to set up a high-tech vaccine production facility in Gödöllõ, 30 kilometres northeast of Budapest. GSK's EUR 100 million investment is one of the company's key strategic investments in Europe. Portfolio.hu (http://www.portfolio.hu/en/cikkek.tdp?cCheck=1&k=2&i=9415)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct